Mefloquine overdosage: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Mefloquine}} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MEFLOQUINE HYDROCHLORIDE TABLET [BARR LABORA...") |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==Overdosage== | |||
===Symptoms and Signs=== | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MEFLOQUINE HYDROCHLORIDE TABLET [BARR LABORATORIES INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=09716a24-d7da-42b2-af29-c03a1b6670bd | publisher = | date = | accessdate = }}</ref> | In cases of overdosage with mefloquine, the symptoms mentioned under Adverse Reactions may be more pronounced. | ||
===Treatment=== | |||
Patients should be managed by symptomatic and supportive care following mefloquine overdose. There are no specific antidotes. Monitor cardiac function (if possible by ECG) and neuropsychiatric status. Provide symptomatic and intensive supportive treatment as required.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MEFLOQUINE HYDROCHLORIDE TABLET [BARR LABORATORIES INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=09716a24-d7da-42b2-af29-c03a1b6670bd | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 04:27, 8 January 2014
| Mefloquine |
|---|
| MEFLOQUINE HYDROCHLORIDE® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Overdosage |
| Dosage and Administration |
| How Supplied |
| Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Overdosage
Symptoms and Signs
In cases of overdosage with mefloquine, the symptoms mentioned under Adverse Reactions may be more pronounced.
Treatment
Patients should be managed by symptomatic and supportive care following mefloquine overdose. There are no specific antidotes. Monitor cardiac function (if possible by ECG) and neuropsychiatric status. Provide symptomatic and intensive supportive treatment as required.[1]
References
Adapted from the FDA Package Insert.